A new class of biomaterial developed by Cornell researchers for an infectious disease nanovaccine effectively boosted immunity in mice with metabolic disorders linked to gut bacteria - a population that shows resistance to traditional flu and polio vaccines.
from EurekAlert! - Breaking News https://ift.tt/2JLQYGU
via IFTTT
No comments:
Post a Comment